Biochemistry · 2015 · 22 citations · 30 references
Life SciencesBiochemistryBiophysicsMembrane BiophysicsMembrane TraffickingStructural BiologyAlzheimer DiseaseAmyloid FormationLipid-protein InteractionsMembrane FusionProtein-lipid InteractionsVesicle FusionAmyloid Assembly PathwaysAmyloid Beta AggregationAmyloid Beta PathwaysAmyloid Beta PeptidesAmyloid StructureCell Membrane BindingMembrane Protein-lipid BindingProtein-lipid Interactions In Fusion
Disruption of the cell membrane by the β-amyloid (Aβ) peptides has been considered as a main mechanism of Alzheimer's disease. The peptide-to-lipid molar ratio (P:L) varies over a broad range biologically. We report here that two of the previously observed Aβ evolution pathways, fibrillation and induction of vesicle fusion, compete with each other when P:L varies in model Aβ-liposome systems. Fibrillation is preferred at higher P:L values, and fusion is promoted at lower P:L values. Structural studies suggest that the same residues in Aβ may involve in both the initial fibrillation and membrane binding at the fusion sites.
30
Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue
Junxia Lu, Wei Qiang, Wai‐Ming Yau et al. · Cell · 2013 · 1.1K citations · Full text
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Juliette Janson, Thomas Laedtke, Joseph E. Parisi et al. · Diabetes · 2004 · 956 citations · Full text
Medicine, Endocrinology, Neurology +17
Marcus Bokvist, Fredrick Lindström, Anthony Watts et al. · Journal of Molecular Biology · 2003 · 378 citations